Here’s a breakdown of the information presented in the text, organized for clarity:
Initial Patient Evaluation:
* Detailed medical history and physical examination
* Tuberculin skin test and interferon-gamma release assay (to screen for tuberculosis)
* complete blood count and complete metabolic panel (general health assessment)
* Lipid fasting profile and viral hepatitis panel (assess cholesterol and liver health)
Follow-up care:
* patients are seen for follow-up at one month and then every three months thereafter.
* This allows for early identification of complications and adjustments to treatment.
Clinic Statistics (Over 20 Years):
* Total patients seen: 403
* Patients returning for follow-up: 237 (58.8%)
* Average visits per patient: 3.7
* Patients receiving at least one biologic therapy: 284 (70.5%)
Financial Assistance & Insurance (Based on Infographic):
* Insurance Coverage: 62% of patients receiving biologics have Medicare, Medicaid, or commercial insurance.
* Pharmaceutical Assistance: 38% of patients receive help from pharmaceutical patient assistance programs.
* Out-of-Pocket Costs: 94.4% of patients on biologics incur no out-of-pocket costs.
